Liberty Biopharma Inc (CVE:LTY – Get Free Report)’s share price passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of C$2.00 and traded as high as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares changing hands.
Liberty Biopharma Trading Up ∞
The company has a market capitalization of C$21.54 million and a price-to-earnings ratio of -12.66. The company has a debt-to-equity ratio of 8.19, a quick ratio of 0.12 and a current ratio of 0.12. The business’s 50-day simple moving average is C$2.00 and its 200-day simple moving average is C$2.00.
Liberty Biopharma Company Profile
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Read More
- Five stocks we like better than Liberty Biopharma
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Rigetti Computing: Cantor’s Bullish Call May Be Just the Start
- What Are Growth Stocks and Investing in Them
- Big Bank Buybacks: Morgan Stanley, Citi, & Wells Fargo Lead
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- 3 Top Stocks Under $20 Riding the “Made in America” Wave
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
